Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

PM

Analysts' Recommendation for PM Stock at $144.65

Shares of Philip Morris International rose to $144.65 during today's afternoon trading session. Despite the 10.4% change, the Large-Cap Tobacco company still trades 5.63% above its average analyst target price of $136.93. So there may be further downside for the Tobacco stock. Philip Morris International has target prices ranging from $102.0 to $150.0 per share, and its average rating is buy.

Philip Morris International's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.6%. The stock's short ratio is 2.12. The company's insiders own 0.12% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 80.8%. In conclusion, we believe there is mixed market sentiment regarding Philip Morris International.

Institutions Invested in Philip Morris International

Date Reported Holder Percentage Shares Value
2024-09-30 Vanguard Group Inc 9% 138,264,582 $19,999,281,054
2024-09-30 Capital World Investors 8% 118,367,624 $17,121,285,479
2024-09-30 Blackrock Inc. 7% 101,685,824 $14,708,346,446
2024-09-30 Capital International Investors 6% 97,503,227 $14,103,354,685
2024-09-30 Capital Research Global Investors 4% 56,340,133 $8,149,318,778
2024-09-30 State Street Corporation 4% 54,711,621 $7,913,762,653
2024-09-30 GQG Partners LLC 3% 42,654,251 $6,169,724,318
2024-09-30 Geode Capital Management, LLC 2% 32,101,324 $4,643,296,147
2024-09-30 JP Morgan Chase & Company 2% 26,914,977 $3,893,116,963
2024-09-30 FMR, LLC 1% 23,168,446 $3,351,199,970
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS